Comment e676 www. thelancet. com/rheumatology Vol 3 October 2021 8375 [90· 1%]
women and 893 [9· 6%] men) between April 3 and May 8, 2020. The most frequent …

The COVID19 pandemic has continued to impact the world, and we are now on track to
exceed two million deaths worldwide. Patients with rheumatic disease were an immediate …

The impact of COVID-19 from the perspective of disease severity and overall mortality
appears to be subsiding; however, what the future holds in terms of the post-COVID …

There is a continuous debate about the risks of increased incidence of COVID-19 in
vulnerable patient groups, which includes patients with rheumatic diseases and especially …

Although viruses can induce rheumatic diseases, the impact of SARS-CoV-2, the virus
behind COVID-19, on the development of systemic rheumatic disease is unclear. COVID-19 …

At the 2019 American College of Rheumatology (ACR) annual meeting, we chaired a
session entitled “Frontiers and Opportunities in Global Rheumatology Research”, which was …

Early in the COVID-19 pandemic, there was concern in the media that the use of non-
steroidal antiinflammatory drugs (NSAIDs), particularly ibuprofen, might exacerbate COVID …

The global coronavirus disease 2019 (COVID-19) crisis is rapidly accelerating pressure on
health systems, especially in the high-income countries that make up most current hotspots …

In The Lancet Rheumatology, Youn Ho Shin and colleagues report a population-based
study from South Korea that provides further real-world evidence of the association between …

With the COVID-19 pandemic, there has been great uncertainty about whether the virus
could exacerbate autoimmune diseases such as rheumatoid arthritis given that infection can …